Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

169.07
+2.361.42%
Volume:2.12M
Turnover:358.04M
Market Cap:262.23B
PE:25.31
High:170.18
Open:167.00
Low:166.78
Close:166.71
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.63
T/O Rate:0.14%
Dividend:3.23
Dividend Rate:1.91%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.21
PE(LYR):25.85

Loading ...

AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study

TIPRANKS
·
3 hours ago

AstraZeneca Climbs Tuesday, Outperforms Market

Dow Jones
·
3 hours ago

AstraZeneca (AZN) Receives a Sell from Deutsche Bank

TIPRANKS
·
Yesterday

Astrazeneca Prices $2.97 Billion Eurobond Offering

MT Newswires Live
·
Yesterday

AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story

TIPRANKS
·
Yesterday

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Yesterday

AstraZeneca Rallies Friday, Outperforms Market

Dow Jones
·
Aug 22

AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors

TIPRANKS
·
Aug 21

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Aug 21

Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib

Deep News
·
Aug 20

Third Indication Approved in China for AstraZeneca's Ultomiris

Stock News
·
Aug 20

Goldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Aug 20

AstraZeneca PLC Stock (AZN) Moved Up by 3.40% on Aug 19: What Signal Does It Send?

TradingKey
·
Aug 20

Movement Alert|AstraZeneca PLC Rises 3.1% in Regular Trading, Multiple Positive Phase III Lung Cancer Results Coupled with Pharma Sector Strength

Market Focus
·
Aug 19

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

UBS Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Aug 19

AstraZeneca Rises Tuesday, Outperforms Market

Dow Jones
·
Aug 19

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Aug 18

AstraZeneca's Biologic Therapy Receives Dual Indication Approval for Launch in China

Stock News
·
Aug 18